Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.46 |
| ▸ | THRB | P10828 | 2/20 | 0.44 |
| ▸ | THRA | P10827 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | ZDHHC20 | Q5W0Z9 | 2/20 | 0.42 |
| ▸ | ZDHHC2 | Q9UIJ5 | 2/20 | 0.42 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | LCK | P06239 | 1/20 | 0.40 |
| ▸ | PPARD | Q03181 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30190518 | 1.00 | TSHR (0.48) | TSHRHPGDSMPD1THRBTHRA | |
| SCHEMBL30190293 | 1.00 | TSHR (0.48) | TSHRHPGDSMPD1THRBTHRA | |
| SCHEMBL29419472 | 1.00 | TSHR (0.48) | TSHRHPGDSMPD1THRBTHRA | |
| SCHEMBL30361174 | 1.00 | TSHR (0.48) | TSHRHPGDSMPD1THRBTHRA | |
| SCHEMBL542079 | 1.00 | TSHR (0.48) | TSHRHPGDSMPD1THRBTHRA | |
| SCHEMBL31520063 | 1.00 | TSHR (0.48) | TSHRHPGDSMPD1THRBTHRA | |
| SCHEMBL4578058 | 1.00 | TSHR (0.48) | TSHRHPGDSMPD1THRBTHRA | |
| SCHEMBL486802 | 1.00 | TSHR (0.48) | TSHRHPGDSMPD1THRBTHRA | |
| SCHEMBL4951003 | 1.00 | TSHR (0.48) | TSHRHPGDSMPD1THRBTHRA | |
| SCHEMBL29419469 | 1.00 | TSHR (0.48) | TSHRHPGDSMPD1THRBTHRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 167 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4555021-B1 | UV-CURABLE COATINGS HAVING HIGH REFRACTIVE INDEX | BASF SE (DE) | 2026-05-13 | — | — | EP | claimed |
| US-20260008936-A1 | UV-CURABLE COATINGS HAVING HIGH REFRACTIVE INDEX | BASF SE (DE) | 2026-01-08 | — | — | US | claimed |
| EP-4555021-A1 | UV-CURABLE COATINGS HAVING HIGH REFRACTIVE INDEX | BASF SE (DE) | 2025-05-21 | — | — | EP | claimed |
| EP-4337734-B1 | COMPOSITIONS, COMPRISING PLATELET-SHAPED TRANSITION METAL PARTICLES | BASF SE (DE) | 2025-04-23 | — | — | EP | claimed |
| CN-119731276-A | UV curable coatings with high refractive index | 巴斯夫欧洲公司 | 2025-03-28 | — | — | CN | claimed |
| US-20240309174-A1 | COMPOSITIONS, COMPRISING SILVER NANOPLATELETS | BASF SE (DE) | 2024-09-19 | — | — | US | claimed |
| EP-4337734-A1 | COMPOSITIONS, COMPRISING PLATELET-SHAPED TRANSITION METAL PARTICLES | BASF SE (DE) | 2024-03-20 | — | — | EP | claimed |
| WO-2024012962-A1 | UV-CURABLE COATINGS HAVING HIGH REFRACTIVE INDEX | BASF SE (DE) | 2024-01-18 | — | — | WO | claimed |
| CN-117203007-A | Composition comprising silver nanoplates | 巴斯夫欧洲公司 | 2023-12-08 | — | — | CN | claimed |
| EP-4234641-A1 | COMPOSITIONS, COMPRISING MODIFIED TITANIUM DIOXIDE NANOPARTICLES AND USES THEREOF | BASF SE (DE) | 2023-08-30 | — | — | EP | claimed |
| WO-2022238468-A1 | COMPOSITIONS, COMPRISING PLATELET-SHAPED TRANSITION METAL PARTICLES | BASF SE (DE) | 2022-11-17 | — | — | WO | claimed |
| WO-2022167377-A1 | COMPOSITIONS, COMPRISING SILVER NANOPLATELETS | BASF SE (DE) | 2022-08-11 | — | — | WO | claimed |
| EP-4743035-A1 | A FUNCTIONAL PACKAGE FOR AN ADHESIVE | Nuceptive Labs, Inc. (US) | 2026-05-20 | — | — | EP | disclosed |
| US-20260132318-A1 | STABILIZING COPOLYMER, ADHESIVE COMPOSITION, METHOD OF MAKING THE SAME, AND ARTICLE INCLUDING THE SAME | 3M INNOVATIVE PROPERTIES CO (US) | 2026-05-14 | — | — | US | disclosed |
| US-20260132298-A1 | A METHOD FOR PRODUCING INTERFERENCE ELEMENTS | BASF SE (DE) | 2026-05-14 | — | — | US | disclosed |
| EP-4555021-B1 | UV-CURABLE COATINGS HAVING HIGH REFRACTIVE INDEX | BASF SE (DE) | 2026-05-13 | — | — | EP | disclosed |
| EP-2436056-A1 | CROSSLINKABLE DIELECTRICS AND METHODS OF PREPARATION AND USE THEREOF | BASF SE (DE) | 2012-04-04 | — | — | EP | disclosed |
| US-20120068314-A1 | CROSSLINKABLE DIELECTRICS AND METHODS OF PREPARATION AND USE THEREOF | POLYERA CORPORATION (US) | 2012-03-22 | — | — | US | disclosed |
| WO-2010136385-A1 | CROSSLINKABLE DIELECTRICS AND METHODS OF PREPARATION AND USE THEREOF | BASF SE (DE) | 2010-12-02 | — | — | WO | disclosed |
| US-20060063087-A1 | Electrostatic latent image developing toner, developer and method of producing the electrostatic latent image developing toner | FUJI XEROX CO., LTD. (JP) | 2006-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260132298-A1 | A METHOD FOR PRODUCING INTERFERENCE ELEMENTS | COPE, COPB2, C9 | TSHR 1841/4885HPGD 4781/4885SMPD1 4451/4885 |
| US-20260132318-A1 | STABILIZING COPOLYMER, ADHESIVE COMPOSITION, METHOD OF MAKING THE SAME, AND ARTICLE INCLUDING THE SAME | PTK2, ACTN1, ITGB7 | TSHR 3956/4885HPGD 2659/4885SMPD1 2454/4885 |
| US-20260008936-A1 | UV-CURABLE COATINGS HAVING HIGH REFRACTIVE INDEX | B2M, MGMT, ITGAM | TSHR 2375/4885HPGD 2834/4885SMPD1 4856/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.